Today’s life sciences organizations are operating in an environment defined by constant change—shifting regulations, evolving portfolios, margin pressure, and persistent talent constraints. In this reality, rigid revenue management models create risk. The ability to adapt—without sacrificing control or compliance—has become a strategic advantage.
In this webinar, Model N explores why optionality is emerging as a core strategy in revenue management, and how hybrid (co‑sourced) operating models give organizations the flexibility to respond to change on their terms. Rather than choosing between fully insourced or fully outsourced approaches, leading pharmaceutical and medical device companies are intentionally designing models that allow them to flex—scaling internal ownership up or down while selectively leveraging external expertise where it delivers the most value.
Drawing from Model N’s latest research and real‑world customer scenarios, we’ll examine what optionality looks like in practice within revenue management. You’ll learn how organizations are using hybrid models to maintain strategic control, reduce operational risk, and create a more resilient foundation that can evolve alongside business needs—all supported by a unified revenue management platform.
Attendees will learn how to:
Whether you’re navigating growth, preparing for regulatory shifts, or modernizing legacy processes, this session will show how treating optionality as a strategy—rather than a contingency—can help life sciences organizations stay agile, compliant, and in control today and in the future.
